Summary: Medicare Prescription Drug Price Negotiation Act of 2007 - Amends title XVIII (Medicare) of the Social Security Act to require the Secretary of Health and Human Services to negotiate with pharmaceutical manufacturers the prices that may be charged to prescription drug plan sponsors and Medicare Advantage organizations for covered part D drugs for part D eligible individuals enrolled under a prescription drug plan or under a Medicare Advantage prescription drug (MA-PD) plan.

medicare prescription drug price negotiation act amends title xviii medicare social security act require secretary health_and_human_services negotiate pharmaceutical manufacturers prices charged prescription drug plan sponsors medicare_advantage organizations covered drugs eligible individuals enrolled prescription drug plan medicare_advantage prescription drug ma-pd plan


Summary: Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to authorize the Secretary of Health and Human Services to negotiate with drug manufacturers and pharmacies prices charged to prescription drug plan (PDP) sponsors and Medicare Advantage organizations for covered part D drugs provided under Medicare.

amends voluntary prescription drug benefit program title xviii medicare social security act authorize secretary health_and_human_services negotiate drug manufacturers pharmacies prices charged prescription drug plan pdp sponsors medicare_advantage organizations covered drugs provided medicare


Summary: Medicare Prescription Drug Enrollment Extension Act of 2007 - Amends title XVIII (Medicare) of the Social Security Act to extend the annual enrollment periods of the Medicare and Medicare Advantage prescription drug benefit programs.

amends title xviii medicare social security act extend annual enrollment periods medicare medicare_advantage prescription drug benefit programs


Summary: Medicaid Obesity Treatment Act of 2007 - Amends title XIX (Medicaid) of the Social Security Act to require Medicaid drug coverage of drugs prescribed for treatment of obesity.

treatment act amends title xix medicaid social security act require medicaid drug coverage drugs prescribed treatment obesity


Summary: Compassionate Assistance for Rape Emergencies Act of 2007 - Prohibits any federal funds from being provided to a hospital under title XVIII (Medicare) of the Social Security Act or to a state, with respect to hospital services, under title XIX (Medicaid) of such Act, unless the hospital meets certain conditions related to a woman who is a victim of sexual assault, including that the hospital: (1) provides the woman with accurate and unbiased information about emergency contraception; (2) offers emergency contraception to the woman; (3) provides the woman such contraception at the hospital on her request; and (4) does not deny any such services because of the inability of the woman or her family to pay.

compassionate assistance rape emergencies act prohibits federal funds provided hospital title xviii medicare social security act state respect hospital services title xix medicaid act hospital meets certain conditions related woman victim sexual assault including hospital provides woman accurate unbiased information emergency contraception offers emergency contraception woman provides woman contraception hospital request deny services inability woman family pay


Summary: Amends part D (Voluntary Prescription Drug Benefit Program ) of title XVIII (Medicare) of the Social Security Act (SSA) to provide for continuity of coverage of prescription drugs under Medicare prescription drug plans for full-benefit dual eligible individuals.Provides for Medicare prescription drug coverage of benzodiazepines and of off-label uses of prescription drugs and biologicals.Amends SSA title XIX (Medicaid) to permit state Medicaid programs to cover Medicare prescription drug copayments for full-benefit dual eligible individuals.Amends SSA title XVIII to authorize the Secretary of Health and Human Services to waive denial of Medicare prescription drug coverage.

amends voluntary prescription drug benefit program title xviii medicare social security act ssa provide continuity coverage prescription drugs medicare prescription drug plans benefit dual eligible individuals provides medicare prescription drug coverage benzodiazepines label uses prescription drugs biologicals amends ssa title xix medicaid permit state medicaid programs cover medicare prescription drug copayments benefit dual eligible individuals amends ssa title xviii authorize secretary health_and_human_services waive denial medicare prescription drug coverage


Summary: Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act (SSA) to limit to $10, adjusted for inflation, the monthly amount of prescription drug cost-sharing for full-benefit dual eligible individuals (eligible for both part D and Medicaid under SSA title XIX) and other lowest-income individuals.

amends voluntary prescription drug benefit program title xviii medicare social security act ssa limit adjusted inflation monthly prescription drug cost sharing benefit dual eligible individuals eligible medicaid ssa title xix lowest income individuals


Summary: Medicare Prescription Drug Improvement Act - Amends title XVIII (Medicare) of the Social Security Act to repeal provisions prohibiting the Secretary of Health and Human Services from interfering with the negotiations between drug manufacturers and pharmacies and prescription drug plan sponsors. Grants the Secretary authority similar to that of the Secretary of Veterans Affairs, Secretary of Defense, and the heads of other Federal agencies and departments that purchase prescription drugs in bulk to negotiate contracts with manufacturers of covered Medicare part D (Voluntary Prescription Drug Benefit Program) drugs.Eliminates the initial coverage limit on the maximum costs that may be recognized for payment purposes (including the annual deductible) with respect to prescription drug benefits. Pharmaceutical Market Access Act of 2007 - Amends the Federal Food, Drug and Cosmetic Act to: (1) repeal certain sections of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 relating to importation of prescription drugs from Canada; and (2) restore previous law. Amends such restored law to direct the Secretary to promulgate regulations allowing qualifying individuals (in addition to pharmacists and wholesalers) to import covered products. Repeals the mandate that the Secretary require that a foreign seller specify the original source of the product and the amount of each lot of the product originally received. Amends provisions regarding the testing of imported covered products. Declares that specified tests shall not be required unless the importer is a wholesaler. Requires such tests to be conducted by the importer-wholesaler unless a product is a prescription drug subject to the provisions of this Act pertaining to counterfeit-resistant packaging. Classifies prescription drugs as misbranded if they do not incorporate specified counterfeit-resistant technologies in packaging. Directs the Secretary to require that the packaging of any subject drug incorporate specified overt optically variable counterfeit-resistant technologies.

title xviii medicare social security act repeal provisions prohibiting secretary health_and_human_services interfering negotiations drug manufacturers pharmacies prescription drug plan sponsors grants secretary authority similar secretary veterans_affairs secretary defense heads federal agencies departments purchase prescription drugs bulk negotiate contracts manufacturers covered medicare voluntary prescription drug benefit program drugs eliminates initial coverage limit maximum costs recognized payment purposes including annual deductible respect prescription drug benefits pharmaceutical market access act amends repeal certain sections medicare_prescription_drug improvement modernization act relating importation prescription drugs canada restore previous law amends restored law direct secretary promulgate regulations allowing qualifying individuals addition pharmacists wholesalers import covered products repeals mandate secretary require foreign seller specify original source product lot product originally received amends provisions testing imported covered products declares specified tests shall required importer wholesaler requires tests conducted importer wholesaler product prescription drug subject provisions act pertaining counterfeit resistant packaging classifies prescription drugs misbranded incorporate specified counterfeit resistant technologies packaging directs secretary require packaging subject drug incorporate specified variable counterfeit resistant technologies


Summary: Medicare Prescription Drug Benefits Gap Elimination Act of 2007 - Directs the Secretary of Health and Human Services to study and report to Congress on how to eliminate the gap in benefits for covered part D drugs under the Medicare prescription drug program under Medicare part D (Voluntary Prescription Drug Benefit Program) of title XVIII of the Social Security Act after a part D eligible individual's costs exceed the initial coverage limit, and before the individual obtains protection against high out-of-pocket expenditures.

medicare prescription drug benefits gap elimination act directs secretary health_and_human_services study report congress eliminate gap benefits covered drugs medicare prescription drug program medicare voluntary prescription drug benefit program title xviii social security act eligible individual costs exceed initial coverage limit individual obtains protection high pocket expenditures


Summary: Prescription Coverage Now Act of 2007 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to direct the Secretary of Health and Human Service to provide for an expedited process for the qualification for low-income assistance through a request to the Secretary of the Treasury for tax return and other information sufficient to identify: (1) whether the individual involved is likely eligible for subsidies; and (2) the amount of premium and cost-sharing subsidies for which they would qualify based on such information. Provides for modification of resource standards for determination of eligibility for low-income subsidy and revision of income and asset rules. Requires indexing of deductibles and cost-sharing above the annual out-of-pocket threshold for individuals with income below 150% of the poverty line. Requires screening by the Commissioner of Social Security for eligibility under Medicare savings programs.Creates a special enrollment period for subsidy eligible individuals. Waives the late enrollment penalty for subsidy eligible individuals.

prescription coverage act amends voluntary prescription drug benefit program title xviii medicare social security act direct secretary health_and_human_service provide expedited process qualification low income assistance request secretary treasury tax return information sufficient identify individual involved likely eligible subsidies premium cost sharing subsidies qualify based information provides modification resource standards determination eligibility low income subsidy revision income asset rules requires indexing deductibles cost sharing annual pocket threshold individuals income poverty line requires screening commissioner_of_social_security eligibility medicare savings programs creates special enrollment period subsidy eligible individuals waives late enrollment penalty subsidy eligible individuals


Summary: Medicare Part D Improvement Act of 2007 - Amends part D (Voluntary Prescription Drug Benefit Program) of the Social Security Act to revise requirements for the Medicare prescription drug program with respect to: (1) counting certain expenditures towards out-of-pocket limits; (2) conforming the late enrollment penalty to the Medicare part B penalty structure; (3) allowing more frequent changes in plans; and (4) removing the asset test and eliminating late enrollment penalties for low-income subsidy eligible individuals. Directs the Secretary of Health and Human Services to study and report to Congress on how to: (1) eliminate the gap in Medicare part D prescription drug coverage created through the application of an initial coverage limit; and (2) finance such elimination.

medicare improvement act amends voluntary prescription drug benefit program social security act revise requirements medicare prescription drug program respect counting certain expenditures pocket limits conforming late enrollment penalty medicare penalty structure allowing frequent changes plans removing asset test eliminating late enrollment penalties low income subsidy eligible individuals directs secretary health_and_human_services study report congress eliminate gap medicare prescription drug coverage created application initial coverage limit finance elimination


Summary: Medicare Drug Savings Through Choice Act of 2007 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to direct the Secretary of Health and Human Services to: (1) offer a Medicare operated prescription drug plan with a service area that consists of the entire United States; (2) negotiate with pharmaceutical manufacturers to reduce the purchase cost of covered Medicare part D drugs; and (3) encourage the use of more affordable therapeutic equivalents. Requires the monthly beneficiary premium charged under such a plan to be uniform nationally. Requires adjustment of such premium amount in case of supplemental prescription drug coverage.

amends voluntary prescription drug benefit program title xviii medicare social security act direct secretary health_and_human_services offer medicare operated prescription drug plan service area consists entire united_states negotiate pharmaceutical manufacturers reduce purchase cost covered medicare drugs encourage use affordable therapeutic equivalents requires monthly beneficiary premium charged plan uniform nationally requires adjustment premium case supplemental prescription drug coverage


Summary: Equity in Prescription Insurance and Contraceptive Coverage Act of 2007 - Amends the Employee Retirement Income Security Act of 1974 (ERISA) and the Public Health Service Act to prohibit a group health plan, and a health insurance issuer providing group coverage, from: (1) excluding or restricting benefits for prescription contraceptive drugs, devices, and outpatient services if the plan provides benefits for other outpatient prescription drugs, devices, or outpatient services; (2) denying eligibility based on use or potential use of such items or services; (3) providing monetary payments or rebates to a covered individual to encourage acceptance of less than the minimum protections available; (4) penalizing, reducing, or limiting a professional's reimbursement because the professional prescribed such drugs or devices or provided such services; or (5) providing incentives to a professional to induce the professional to withhold such drugs, devices, or services. Applies such prohibitions to coverage offered in the individual market.

equity prescription insurance contraceptive coverage act amends employee retirement income security act erisa public_health_service_act prohibit group health plan health insurance issuer providing group coverage excluding restricting benefits prescription contraceptive drugs devices outpatient services plan provides benefits outpatient prescription drugs devices outpatient services denying eligibility based use potential use items services providing monetary payments rebates covered individual encourage acceptance minimum protections available penalizing reducing limiting professional reimbursement professional prescribed drugs devices provided services providing incentives professional induce professional withhold drugs devices services applies prohibitions coverage offered individual market


Summary: Medicare Residency Program Technical Correction Act of 2007 - Amends title XVIII (Medicare) of the Social Security Act with respect to payments to hospitals for the direct graduate medical education (DGME) costs of inpatient hospital services, particularly the redistribution among qualifying hospitals of unused resident positions which figure in the calculation of DGME costs.Requires a specified adjustment to the reduction of Medicare resident positions where that reduction was based on a cost report subsequently settled, whether as a result of an appeal or otherwise, if the reference resident level under such settled cost report is higher than the resident level used for the reduction.

amends title xviii medicare social security act respect payments hospitals direct graduate medical education costs inpatient hospital services particularly redistribution qualifying hospitals unused resident positions figure calculation costs requires specified adjustment reduction medicare resident positions reduction based cost report subsequently settled result appeal reference resident level settled cost report higher resident level reduction


Summary: Medicare Prescription Drug Savings for Our Seniors (Medicare Prescription Drug SOS) Act of 2007 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act (SSA) to direct the Secretary of Health and Human Services to: (1) offer one or more Medicare operated prescription drug plans (PDPs) with a service area consisting of the entire United States; and (2) negotiate with pharmaceutical manufacturers to reduce the purchase cost of covered part D drugs. Requires the monthly beneficiary premium for qualified prescription drug coverage and access to negotiated prices to be uniform nationally. Provides for auto-enrollment of subsidy eligible individuals in Medicare operated PDPs.Amends SSA title XIX (Medicaid) to provide for the use of 2005 as base in computing the state clawback provision. Amends SSA title XVIII (Medicare) to eliminate part D cost-sharing for certain non-institutionalized full-benefit dual eligible individuals. Provides for: (1) expedited low-income subsidies under the Medicare PDP; (2) indexing of deductible and cost-sharing for certain individuals; and (3) Commissioner of Social Security screening for Medicare savings program eligibility. Sets forth anti-fraud and abuse provisions. Provides for protection against a decrease in Social Security benefits owing to part D Medicare premium increases. Prohibits late enrollment penalties for months before January 2008. Allows a one-time change in plan during first year of enrollment. Prohibits a PDP sponsor from removing a covered part D drug from the plan formulary, downgrading its cost-sharing status, or otherwise introducing a barrier to access to covered part D drugs, without advance notice. Requires Medicare part D formularies to cover all drugs in six specified therapeutic categories. Makes benzodiazepines covered part D drugs, subject to review by the Secretary. Eliminates the MA Regional Stabilization Fund and certain Medicare Advantage overpayments.Requires prompt payment of clean claims by Medicare and Medicare Advantage PDPs. Prohibits co-branding. Extends part D coverage to medication therapy management services.

act amends voluntary prescription drug benefit program title xviii medicare social security act ssa direct secretary health_and_human_services offer medicare operated prescription drug plans pdps service area consisting entire united_states negotiate pharmaceutical manufacturers reduce purchase cost covered drugs requires monthly beneficiary premium qualified prescription drug coverage access negotiated prices uniform nationally provides auto enrollment subsidy eligible individuals medicare operated pdps amends ssa title xix medicaid provide use base computing state provision amends ssa title xviii medicare eliminate cost sharing certain non institutionalized benefit dual eligible individuals provides expedited low income subsidies medicare pdp indexing deductible cost sharing certain individuals commissioner social_security screening medicare savings program eligibility sets forth anti fraud abuse provisions provides protection decrease social_security benefits owing medicare premium increases prohibits late enrollment penalties months january allows time change plan year enrollment prohibits pdp sponsor removing covered drug plan formulary cost sharing status introducing barrier access covered drugs advance notice requires medicare formularies cover drugs specified therapeutic categories makes benzodiazepines covered drugs subject review secretary eliminates certain medicare_advantage overpayments requires prompt payment clean claims medicare medicare_advantage pdps prohibits branding extends coverage medication therapy management services


Summary: Medicaid Prescription Drug Rebate Equalization Act of 2007 - Amends title XIX (Medicaid) of the Social Security Act to reduce the costs of prescription drugs for enrollees of Medicaid managed care organizations by extending to such organizations the discounts offered under fee-for-service Medicaid plans.Requires the state contract with a Medicaid managed care organization to provide that: (1) payment for covered outpatient drugs dispensed to Medicaid-eligible individuals enrolled with the organization shall be subject to the same rebate as the state is subject to; and (2) the state shall allow the organization to collect such rebates from manufacturers.Requires also that capitation rates paid to the organization be: (1) based on actual cost experience related to rebates; and (2) subject to the federal regulations requiring actuarially sound rates.

amends title xix medicaid social security act reduce costs prescription drugs enrollees medicaid managed care organizations extending organizations discounts offered fee service medicaid plans requires state contract medicaid managed care organization provide payment covered outpatient drugs dispensed medicaid eligible individuals enrolled organization shall subject rebate state subject state shall allow organization collect rebates manufacturers requires capitation rates paid organization based actual cost experience related rebates subject federal regulations requiring actuarially sound rates


Summary: Medicare Part D Drug Class Protection Act of 2007 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to require that Medicare prescription drug plans using formularies cover all drugs included in six specified therapeutic categories. Sets forth special requirements for reconsideration of coverage determinations, and appeals for drugs included in such categories. Establishes reporting requirements for drugs in these categories.

medicare drug class protection act amends voluntary prescription drug benefit program title xviii medicare social security act require medicare prescription drug plans formularies cover drugs included specified therapeutic categories sets forth special requirements reconsideration coverage determinations appeals drugs included categories establishes reporting requirements drugs categories


Summary: Patient and Pharmacy Protection Act of 2007 - Amends title XIX (Medicaid) of the Social Security Act, as amended by the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act, 2007, to limit to Controlled Substances Act schedule II narcotics the use of tamper-resistant prescription pads required under the Medicaid program for payment of amounts expended for covered outpatient drugs.

patient pharmacy protection act amends title xix medicaid social security act amended katrina_recovery iraq_accountability_appropriations_act limit controlled substances act schedule narcotics use tamper resistant prescription pads required medicaid program payment amounts expended covered outpatient drugs


Summary: Saving Our Community Pharmacies Act of 2007 - Amends title XIX (Medicaid) of the Social Security Act to provide for: (1) use of median retail acquisition cost as the basis for Medicaid reimbursement limits on generic drugs; and (2) establishment of an evidence-based prescription drug program. Directs the Comptroller General to study and report to Congress on the costs of community retail pharmacies to dispense prescription drugs.

saving community pharmacies act amends title xix medicaid social security act provide use median retail acquisition cost basis medicaid reimbursement limits generic drugs establishment evidence based prescription drug program directs comptroller_general study report congress costs community retail pharmacies dispense prescription drugs


Summary: Access to Community Pharmacy Preservation Act of 2007 - Amends title XIX (Medicaid) of the Social Security Act (SSA) to require states to pay dispensing fees for Medicaid covered outpatient drugs. Directs a state which provides medical assistance for covered outpatient drugs to establish a minimum Medicaid dispensing fee of at least $8 per unit for covered outpatient multiple source drugs. Revises the requirement for application of the federal upper pharmacy reimbursement limit in the calculation of the payment for covered outpatient drugs. Increases from 250% to 300% the percentage of the average manufacturer price (AMP) the Secretary of Health and Human Services is required to substitute for 150% of the published price. Repeals the state option to increase the cap on the equity asset test for an individual's eligibility for long-term care assistance under Medicaid. Directs the Secretary, for purposes of verifying financial eligibility for Medicaid, to collaborate with the Commissioner of Social Security for use of the Commissioner's system for obtaining information held by financial institutions in order to verify eligibility for benefits under SSA title VI (Supplemental Security Income) (SSI).

amends title xix medicaid social security act ssa require states pay dispensing fees medicaid covered outpatient drugs directs state provides medical assistance covered outpatient drugs establish minimum medicaid dispensing fee unit covered outpatient multiple source drugs revises requirement application federal upper pharmacy reimbursement limit calculation payment covered outpatient drugs increases percentage average manufacturer price secretary health_and_human_services required substitute published price repeals state option increase cap equity asset test individual eligibility long term care assistance medicaid directs secretary purposes verifying financial eligibility medicaid collaborate commissioner_of_social_security use commissioner system obtaining information held financial institutions order verify eligibility benefits ssa title ssi


Summary: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007 - Amends SSA title II (Old Age, Survivors and Disability Insurance) (OASDI) to: (1) continue entitlement to prescription drugs used in immunosuppressive therapy furnished to an individual who receives a kidney transplant for which payment is made under Medicare; and (2) extend Medicare secondary payer requirements for end stage renal disease (ESRD) beneficiaries. Amends title XVIII (Medicare ) of SSA to apply special rules to kidney transplant recipients receiving additional coverage for immunosuppressive drugs. Deems such individual to be enrolled under Medicare part B. Makes him or her responsible for the full amount of the applicable premiums. Applies deductible and coinsurance requirements to the provision of such drugs. Amends the Public Health Service Act, the Employee Retirement Income Security Act of 1974 (ERISA), and the Internal Revenue Code to set forth requirements for group health plans to provide coverage of immunosuppressive drugs for kidney transplant patients.

comprehensive immunosuppressive drug coverage kidney transplant patients act amends ssa title survivors disability insurance oasdi continue entitlement prescription drugs immunosuppressive therapy furnished individual receives kidney transplant payment medicare extend medicare secondary payer requirements end stage renal disease esrd beneficiaries amends title xviii medicare ssa apply special rules kidney transplant recipients receiving additional coverage immunosuppressive drugs deems individual enrolled medicare responsible applicable premiums applies deductible coinsurance requirements provision drugs amends public_health_service_act employee retirement income security act erisa internal revenue code set forth requirements group health plans provide coverage immunosuppressive drugs kidney transplant patients


Summary: Fair Medicaid Drug Payment Act of 2007 - Amends title XIX (Medicaid) of the Social Security Act to direct the Secretary of Health and Human Services to calculate the federal upper reimbursement limit as no less than 300% of the weighted average (based on utilization) of the most recent average manufacturer prices (AMPs) for pharmaceutically and therapeutically equivalent multiple source drug products available for purchase by retail community pharmacies on a nationwide basis. Directs the Secretary to implement a smoothing process for AMPs to ensure that federal upper reimbursement limits do not vary significantly from month to month as a result of rebates, discounts, and other pricing practices. Requires a state plan to subject to prior authorization all covered outpatient drug products that are innovator multiple source drugs, if such drug products are more expensive than other biologically and therapeutically equivalent drug products available for purchase in that state by retail community pharmacies. Revises requirements for monthly reports to the Secretary of price information by manufacturers subject to rebate agreements.

fair medicaid drug payment act amends title xix medicaid social security act direct secretary health_and_human_services calculate federal upper reimbursement limit weighted average based utilization recent average manufacturer prices amps therapeutically equivalent multiple source drug products available purchase retail community pharmacies nationwide basis directs secretary implement process amps ensure federal upper reimbursement limits vary significantly month month result rebates discounts pricing practices requires state plan subject prior authorization covered outpatient drug products innovator multiple source drugs drug products expensive biologically therapeutically equivalent drug products available purchase state retail community pharmacies revises requirements monthly reports secretary price information manufacturers subject rebate agreements


Summary: Medicare Prescription Drug Savings and Choice Act of 2007 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to provide for: (1) establishment of one or more Medicare operated prescription drug plan options; (2) an appeals process for denials of benefits under a Medicare operated prescription drug plan; and (3) pharmacy payments under such a plan.

medicare_prescription_drug_savings choice act amends voluntary prescription drug benefit program title xviii medicare social security act provide establishment medicare operated prescription drug plan options appeals process denials benefits medicare operated prescription drug plan pharmacy payments plan


Summary: Prevention Through Affordable Access Act - Amends title XIX (Medicaid) of the Social Security Act to revise requirements for the best price component of the formula for determination of the Medicaid rebate for a covered single source outpatient drug or a covered innovator multiple source outpatient drug. (Under current law, best prices shall not take into account prices that are merely nominal in amount.) Revises the list of entities to which sales by a manufacturer of covered outpatient drugs at nominal prices shall be considered to be sales at a nominal price, or merely nominal in amount (and thus excluded from computation of the best price for such drugs). Adds to such list any entity that is: (1) operated by a health center of an institution of higher education, primarily for its students (university-based clinic); or (2) a public or private nonprofit entity that provides family planning services under the Public Health Service Act (safety-net clinic).

prevention affordable access act amends title xix medicaid social security act revise requirements best price component formula determination medicaid rebate covered single source outpatient drug covered innovator multiple source outpatient drug current law best prices shall account prices merely nominal revises list entities sales manufacturer covered outpatient drugs nominal prices shall considered sales nominal price merely nominal excluded computation best price drugs adds list entity operated health center institution higher education primarily students university based clinic public private nonprofit entity provides family planning services public_health_service_act safety net clinic


Summary: Health Insurance Tax Credit Assistance Act of 2007 - Amends the Internal Revenue Code to allow a tax credit for charitable contributions to tax-exempt charities which subsidize health insurance premiums and pharmacy co-payments of uninsured individuals or individuals who cannot otherwise afford health insurance or drug treatments.

amends internal revenue code allow tax credit charitable contributions tax exempt charities subsidize health insurance premiums pharmacy payments uninsured individuals individuals afford health insurance drug treatments


Summary: Reforming an Entitlement through Premium Adjustments based on Income Resources (REPAIR) Act of 2007 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to require an income-related reduction in the part D premium subsidy. Declares that, in the case of an individual whose modified adjusted gross income exceeds a certain applicable threshold amount for a month after December 2008, the monthly amount of the part D premium subsidy shall be reduced (and the monthly beneficiary premium shall be increased) by the monthly adjustment amount determined according to a specified formula.

reforming entitlement based act amends voluntary prescription drug benefit program title xviii medicare social security act require income related reduction premium subsidy declares case individual modified adjusted gross income exceeds certain applicable threshold month december monthly premium subsidy shall reduced monthly beneficiary premium shall increased monthly adjustment determined according specified formula


Summary: Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007 - Amends title XVIII (Medicare) of the Social Security Act to require the Secretary of Health and Human Services to: (1) make incentive payments for physician use of an electronic prescription drug program (E-prescribing); and (2) reduce by 10% the fee schedule amount for failure to use E-prescribing. Directs the Administrator of the Centers for Medicare & Medicaid Services to report to Congress on progress on implementing E-prescribing under the Medicare electronic prescription drug program.

meds act amends title xviii medicare social security act require secretary health_and_human_services incentive payments physician use electronic prescription drug program prescribing reduce fee schedule failure use prescribing directs administrator centers report congress progress implementing prescribing medicare electronic prescription drug program


Summary: Amends title XVIII (Medicare) of the Social Security Act to repeal the income-related increase in Medicare part B (Supplementary Medical Insurance) premiums that was enacted as part of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, as amended by the Deficit Reduction Act of 2005.

amends title xviii medicare social security act repeal income related increase medicare supplementary_medical_insurance premiums enacted medicare_prescription_drug improvement modernization act amended deficit reduction act


Summary: Medicare Prescription Drug Affordability Act of 2008 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to: (1) limit Medicare part D prescription drug plan (PDP) cost increases to the Social Security cost-of-living increase; and (2) direct the Secretary of Health and Human Services to negotiate with pharmaceutical manufacturers the prices that may be charged to PDP sponsors and MedicareAdvantage (MA) organizations for covered part D drugs for part D eligible individuals who are enrolled under a PDP or under an MA-Prescription Drug (MA-PD) plan.

amends voluntary prescription drug benefit program title xviii medicare social security act limit medicare prescription drug plan pdp cost increases social_security cost living increase direct secretary health_and_human_services negotiate pharmaceutical manufacturers prices charged pdp sponsors medicareadvantage organizations covered drugs eligible individuals enrolled pdp ma-prescription_drug ma-pd plan


Summary: Medicare Prescription Drug Cost Equalization Act - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to: (1) require application to specialty tier drugs (very high cost and unique items) of the process for exception from the tiered cost-sharing for drugs included within a formulary; and (2) limit to 25% the Medicare cost-sharing for such specialty tier drugs. (Under an exception, a nonpreferred drug could be covered under the terms applicable for preferred drugs if the prescribing physician determines that the preferred drug for treatment of the same condition either would not be as effective for the individual, or would have adverse effects for the individual, or both. )

voluntary prescription drug benefit program title xviii medicare social security act require application specialty tier drugs high cost unique items process exception tiered cost sharing drugs included formulary limit medicare cost sharing specialty tier drugs exception drug covered terms applicable preferred drugs prescribing physician determines preferred drug treatment condition effective individual adverse effects individual


Summary: Medicare Drugs for Seniors (MEDS) Act of 2008 -Amends title XVIII (Medicare) of the Social Security Act to replace the current part D (Voluntary Prescription Drug Benefit Program) program, adopted by the Medicare Prescription Drug, Improvement and Modernization Act of 2003, with a revised prescription drug benefit program under a new part D (Prescription Medicine Benefit for the Aged and Disabled) for all Medicare beneficiaries. Provides for reductions in the price of prescription drugs for Medicare beneficiaries. Amends the Federal Food, Drug, and Cosmetic Act to: (1) revise requirements with respect to the commercial and personal importation of prescription drugs and the disposition of certain drugs denied admission; and (2) prescribe requirements with respect to Internet sales of prescription drugs. Provides that if any federal agency or any non-profit entity undertakes federally funded health care research and development, and is to convey or provide a patent or other exclusive right to use such research and development for a drug or other health care technology, such agency or entity shall not make such conveyance or provide such patent or other right until the recipient first agrees to a reasonable pricing agreement with the Secretary of Health and Human Services, or the Secretary determines that the public interest is served by a waiver of the reasonable pricing agreement. Sets forth Medigap transition requirements.

seniors meds act title xviii medicare social security act replace current voluntary prescription drug benefit program program adopted revised prescription drug benefit program new prescription medicine benefit aged disabled medicare beneficiaries provides reductions price prescription drugs medicare beneficiaries amends cosmetic act revise requirements respect commercial personal importation prescription drugs disposition certain drugs denied admission prescribe requirements respect internet sales prescription drugs provides federal agency non profit entity federally funded health care research development convey provide patent exclusive right use research development drug health care technology agency entity shall conveyance provide patent right recipient agrees reasonable pricing agreement secretary health_and_human_services secretary determines public interest served waiver reasonable pricing agreement sets forth medigap transition requirements


Summary: Medicare Prescription Drug Price Negotiation Act of 2007 - Expresses the sense of Congress that Congress should enact, and the President should sign, legislation to amend part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to provide for fair prescription drug prices for Medicare beneficiaries.

medicare prescription drug price negotiation act expresses sense congress congress enact president sign legislation amend voluntary prescription drug benefit program title xviii medicare social security act provide fair prescription drug prices medicare beneficiaries


Summary: Generics First Act of 2007 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to exclude from coverage under the Medicare part D prescription drug program all nongeneric (brand name) drugs unless no generic drug has been approved, and the brand name drug is determined to be medically necessary.

amends voluntary prescription drug benefit program title xviii medicare social security act exclude coverage medicare prescription drug program brand drugs generic drug approved brand drug determined medically necessary


Summary: Medicare Enhancements for Needed Drugs Act of 2007 - Directs the Comptroller General to review and report to Congress on the retail cost of prescription drugs in the United States during 2000 through 2006, with an emphasis on the prescription drugs most utilized for individuals age 65 or older.Requires the Comptroller General to conduct an ongoing study that compares the average retail cost in the United States for each of the 20 most utilized prescription drugs for individuals age 65 or older with: (1) the average prices at which private health plans, the Department of Defense under the Defense Health Program, and the Department of Veterans Affairs acquire each such drug; and (2) the average negotiated price for each such drug that eligible beneficiaries have access to under a Medicare prescription drug plan providing only basic prescription drug coverage.Amends title XVIII (Medicare) of the Social Security Act (SSA) to include in the comparative plan information for beneficiaries under new Medicare part D (Voluntary Prescription Drug Benefit Program) a comparison of average aggregate prescription drug plan beneficiary costs and savings with such costs for a beneficiary with no prescription drug plan. Repeals the prohibition against interference by the Secretary of Health and Human Services with the negotiations between drug manufacturers and pharmacies and prescription drug plan sponsors. Authorizes the Secretary instead, like other federal entities that purchase prescription drugs in bulk, to negotiate contracts with manufacturers of covered part D drugs. Requires the savings to the Medicare Prescription Drug Account through the use of authority provided under this Act to be used to strengthen the part D program and to reduce the federal deficit. Requires the Secretary to ensure that each part D eligible individual has: (1) a choice of enrollment in a comprehensive prescription drug plan in the area in which the individual resides; or (2) in any case in which such a plan is not available, the opportunity to enroll in a comprehensive fallback prescription drug plan.

needed drugs act directs comptroller general review report congress retail cost prescription drugs united_states emphasis prescription drugs utilized individuals age older requires comptroller general conduct ongoing study compares average retail cost united_states utilized prescription drugs individuals age older average prices private health plans department_of_defense defense_health_program department_of_veterans_affairs acquire drug average negotiated price drug eligible beneficiaries access medicare prescription drug plan providing basic prescription drug coverage amends title xviii medicare social security act ssa include comparative plan information beneficiaries new medicare voluntary prescription drug benefit program comparison average aggregate prescription drug plan beneficiary costs savings costs beneficiary prescription drug plan repeals prohibition interference secretary health_and_human_services negotiations drug manufacturers pharmacies prescription drug plan sponsors authorizes secretary instead like federal entities purchase prescription drugs bulk negotiate contracts manufacturers covered drugs requires savings use authority provided act strengthen program reduce federal deficit requires secretary ensure eligible individual choice enrollment comprehensive prescription drug plan area individual resides case plan available opportunity enroll comprehensive fallback prescription drug plan


Summary: Prescription Drug and Health Improvement Act of 2007 - Amends title XVIII (Medicare) of the Social Security Act (SSA) with respect to prescription drug plans to repeal the prohibition against interference by the Secretary of Health and Human Services with negotiations between drug manufacturers and pharmacies and prescription drug plan sponsors, and against the Secretary's requiring a particular formulary or instituting a price structure for the reimbursement of covered part D (Voluntary Prescription Drug Benefit Program) drugs. Grants the Secretary authority similar to that of other federal entities that purchase prescription drugs in bulk to negotiate contracts with manufacturers of covered part D drugs.

prescription drug health improvement act amends title xviii medicare social security act ssa respect prescription drug plans repeal prohibition interference secretary health_and_human_services negotiations drug manufacturers pharmacies prescription drug plan sponsors secretary requiring particular formulary instituting price structure reimbursement covered voluntary prescription drug benefit program drugs grants secretary authority similar federal entities purchase prescription drugs bulk negotiate contracts manufacturers covered drugs


Summary: Drug Rebate Equalization Act of 2007 - Amends title XIX (Medicaid) of the Social Security Act to reduce the costs of prescription drugs for enrollees of Medicaid managed care organizations by extending to such organizations the discounts offered under fee-for-service Medicaid plans. Requires the state contract with a Medicaid managed care organization to provide that: (1) payment for covered outpatient drugs dispensed to Medicaid-eligible individuals enrolled with the organization shall be subject to the same rebate as the state is subject to; and (2) the state shall allow the organization to collect such rebates from manufacturers. Requires also that capitation rates paid to the organization be: (1) based on actual cost experience related to rebates; and (2) subject to the federal regulations requiring actuarially sound rates.

drug rebate equalization act amends title xix medicaid social security act reduce costs prescription drugs enrollees medicaid managed care organizations extending organizations discounts offered fee service medicaid plans requires state contract medicaid managed care organization provide payment covered outpatient drugs dispensed medicaid eligible individuals enrolled organization shall subject rebate state subject state shall allow organization collect rebates manufacturers requires capitation rates paid organization based actual cost experience related rebates subject federal regulations requiring actuarially sound rates


Summary: Pharmacist Access and Recognition in Medicare (PhARM) Act of 2007 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to require prompt payment of clean claims to pharmacies by prescription drug plans and Medicare Advantage prescription drug plans. Defines prompt payment as within 14 days from submission for claims submitted electronically, and within 30 days for claims submitted otherwise. Requires payment of interest, also, if a payment is not issued, mailed, or otherwise transmitted within the applicable number of calendar days. Prohibits a Medicare prescription drug card issued by a prescription drug plan sponsor from displaying the name, brand, or trademark (co-branding) of any pharmacy. Revises requirements for a covered medication therapy management program, allowing it to be furnished by a health care provider, other than a pharmacist, with advanced training in medication management. Requires the Secretary of Health and Human Services to specify: (1) the population of part D eligible individuals appropriate for services under a medication therapy management program, based on certain characteristics; and (2) a minimum defined package of medication therapy management services that shall be provided to each enrollee.Revises requirements for pharmacy fees.Directs the Secretary to establish: (1) a two-year demonstration program to examine the impact of medication therapy management furnished by a pharmacist in a community-based or ambulatory-based setting on quality of care, spending, and patient health; and (2) a Best Practices Commission to develop a best practices model for medication therapy management.

recognition medicare act amends voluntary prescription drug benefit program title xviii medicare social security act require prompt payment clean claims pharmacies prescription drug plans medicare_advantage prescription drug plans defines prompt payment days submission claims submitted electronically days claims submitted requires payment interest payment issued mailed transmitted applicable number calendar days prohibits medicare prescription drug card issued prescription drug plan sponsor displaying brand trademark branding pharmacy revises requirements covered medication therapy management program allowing furnished health care provider pharmacist advanced training medication management requires secretary health_and_human_services specify population eligible individuals appropriate services medication therapy management program based certain characteristics minimum defined package medication therapy management services shall provided enrollee revises requirements pharmacy fees directs secretary establish year demonstration program examine impact medication therapy management furnished pharmacist community based ambulatory based setting quality care spending patient health develop best practices model medication therapy management


Summary: Medicare Access to Critical Medications Act of 2007 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to require prescription drug plan (PDP) formularies to include all or substantially all covered part D drugs in the therapeutic classes: (1) anticonvulsants; (2) antineoplastics; (3) antiretrovirals; (4) antidepressants; (5) antipsychotics; and (6) immunosuppressants.Prohibits the application of a utilization management tool, such as prior authorization or step therapy, to such drugs in certain cases.Prescribes requirements for treatment of such drugs when a determination or reconsideration is requested, as well as the treatment of appeals for such drugs.Establishes data reporting requirements for such drug categories and classes.

medicare access critical medications act amends voluntary prescription drug benefit program title xviii medicare social security act require prescription drug plan pdp formularies include substantially covered drugs therapeutic classes antidepressants prohibits application utilization management tool prior authorization step therapy drugs certain cases prescribes requirements treatment drugs determination reconsideration requested treatment appeals drugs establishes data reporting requirements drug categories classes


Summary: Fair Medicaid Drug Payment Act of 2007 - Amends title XIX (Medicaid) of the Social Security Act to direct the Secretary of Health and Human Services to calculate the federal upper reimbursement limit as no less than 300% of the weighted average (based on utilization) of the most recent average manufacturer prices (AMPs) for pharmaceutically and therapeutically equivalent multiple source drug products available for purchase by retail community pharmacies on a nationwide basis. Directs the Secretary to implement a smoothing process for AMPs to ensure that federal upper reimbursement limits do not vary significantly from month to month as a result of rebates, discounts, and other pricing practices. Requires a state plan to subject to prior authorization all covered outpatient drug products that are innovator multiple source drugs, if such drug products are more expensive than other biologically and therapeutically equivalent drug products available for purchase in that state by retail community pharmacies. Revises requirements for monthly reports to the Secretary of price information by manufacturers subject to rebate agreements.

fair medicaid drug payment act amends title xix medicaid social security act direct secretary health_and_human_services calculate federal upper reimbursement limit weighted average based utilization recent average manufacturer prices amps therapeutically equivalent multiple source drug products available purchase retail community pharmacies nationwide basis directs secretary implement process amps ensure federal upper reimbursement limits vary significantly month month result rebates discounts pricing practices requires state plan subject prior authorization covered outpatient drug products innovator multiple source drugs drug products expensive biologically therapeutically equivalent drug products available purchase state retail community pharmacies revises requirements monthly reports secretary price information manufacturers subject rebate agreements


Summary: Pharmacy Access Improvement (PhAIm) Act of 2007 - Amends part D (Voluntary Prescription Drug Benefit Program ) of title XVIII (Medicare) of the Social Security Act (SSA) with respect to participating pharmacies and standards for access to them. Requires that such standards ensure that enrollees residing in long-term care facilities have access to a long-term care network pharmacy.Requires prompt payment of clean claims to pharmacies by prescription drug plans (PDPs) and Medicare Advantage prescription drug plans (MA-PD Plans). Defines prompt payment as payment occurring within 14 days from submission for claims submitted electronically, and within 30 days for claims submitted otherwise. Requires payment of interest if a payment is not issued, mailed, or otherwise transmitted within the applicable number of calendar days.Directs the Secretary of Health and Human Services to establish a 24-hour toll-free telephone number dedicated to providing Medicare prescription drug benefit information to pharmacists and pharmacy staff.Requires PDP sponsors to establish toll-free pharmacy and physician and provider hotlines.Prohibits a Medicare prescription drug card issued by a PDP sponsor from displaying the name, brand, logo, or trademark (co-branding) of any pharmacy.Provides for submission of claims by pharmacies located in or contracting with long-term care facilities.Requires the Inspector General of the Department of Health and Human Services to analyze and report to the Secretary on the cost of dispensing covered part D drugs under a PDP or an MA-PD plan.Provides that, if the PDP sponsor uses a standard for reimbursement of pharmacies based on the cost of a drug, each contract entered into with such sponsor with respect to the plan shall require the sponsor to update the standard at least once every seven days.

pharmacy access improvement act amends voluntary prescription drug benefit program title xviii medicare social security act ssa respect participating pharmacies standards access requires standards ensure enrollees residing long term care facilities access long term care network pharmacy requires prompt payment clean claims pharmacies prescription drug plans pdps medicare_advantage prescription drug plans ma-pd plans defines prompt payment payment occurring days submission claims submitted electronically days claims submitted requires payment interest payment issued mailed transmitted applicable number calendar days directs secretary health_and_human_services establish hour toll free telephone number dedicated providing medicare prescription drug benefit information pharmacists pharmacy staff requires pdp sponsors establish toll free pharmacy physician provider hotlines prohibits medicare prescription drug card issued pdp sponsor displaying brand logo trademark branding pharmacy provides submission claims pharmacies located contracting long term care facilities requires inspector general department_of_health_and_human_services analyze report secretary cost dispensing covered drugs pdp ma-pd plan provides pdp sponsor uses standard reimbursement pharmacies based cost drug contract entered sponsor respect plan shall require sponsor update standard seven days


Summary: Amends title XIX (Medicaid) of the Social Security Act, as amended by the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act, 2007, to: (1) apply the required use of tamper-resistant prescription pads under the Medicaid Program at first only to Controlled Substances Act schedule II narcotic drugs prescribed after September 30, 2007; and (2) delay the application of the requirement to other covered outpatient prescription drugs until after March 31, 2009.

amends title xix medicaid social security act amended katrina_recovery iraq_accountability_appropriations_act apply required use tamper resistant prescription pads medicaid program controlled substances act schedule narcotic drugs prescribed september delay application requirement covered outpatient prescription drugs march


Summary: Patient and Pharmacy Protection Act of 2007 - Amends the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act, 2007 to delay for six months, from September 30, 2007, through March 31, 2008, the effective date of the requirement to use tamper-resistant prescription pads under title XIX (Medicaid) of the Social Security Act to prescribe covered outpatient drugs.

patient pharmacy protection act amends katrina_recovery iraq_accountability_appropriations_act delay months september march effective date requirement use tamper resistant prescription pads title xix medicaid social security act prescribe covered outpatient drugs


Summary: Medicare Prescription Drug Gap Reduction Act of 2007 - Amends title XVIII (Medicare) of the Social Security Act (SSA) to reduce the coverage gap in prescription drug coverage under SSA part D (Voluntary Prescription Drug Benefit Program), based on savings to the Medicare program resulting from the negotiation of prescription drug prices.Grants the Secretary of Health and Human Services authority similar to that of other federal entities that purchase prescription drugs in bulk to negotiate contracts with manufacturers of covered part D drugs.States that the Secretary shall be required to: (1) negotiate contracts with manufacturers of covered part D drugs for each fallback prescription drug plan; and (2) participate in negotiation of contracts of any covered part D drug upon request of an approved prescription drug plan or Medicare Advantage Prescription Drug Plan.Prohibits the Secretary from requiring a particular formulary or instituting a price structure for the reimbursement of covered part D drugs in order to carry out, and promote competition, under part D.

amends title xviii medicare social security act ssa reduce coverage gap prescription drug coverage ssa voluntary prescription drug benefit program based savings medicare program resulting negotiation prescription drug prices grants secretary health_and_human_services authority similar federal entities purchase prescription drugs bulk negotiate contracts manufacturers covered drugs states secretary shall required negotiate contracts manufacturers covered drugs fallback prescription drug plan participate negotiation contracts covered drug request approved prescription drug plan prohibits secretary requiring particular formulary instituting price structure reimbursement covered drugs order carry promote competition


Summary: Medicare Mental Health Prescription Drug Access Act of 2007 - Amends title XVIII (Medicare) of the Social Security Act to cover barbiturates and benzodiazepines as Medicare part D drugs, beginning in 2008.

amends title xviii medicare social security act cover benzodiazepines medicare drugs beginning


Summary: Medicare Prescription Drug Savings and Choice Act of 2007 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to provide for: (1) establishment of one or more Medicare operated prescription drug plan options; (2) an appeals process for denials of benefits under a Medicare operated prescription drug plan; and (3) pharmacy payments under such a plan.

medicare_prescription_drug_savings choice act amends voluntary prescription drug benefit program title xviii medicare social security act provide establishment medicare operated prescription drug plan options appeals process denials benefits medicare operated prescription drug plan pharmacy payments plan


Summary: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007 - Amends SSA title II (Old Age, Survivors and Disability Insurance) (OASDI) to: (1) continue entitlement to prescription drugs used in immunosuppressive therapy furnished to an individual who receives a kidney transplant for which payment is made under Medicare; and (2) extend Medicare secondary payer requirements for end stage renal disease (ESRD) beneficiaries. Amends title XVIII (Medicare ) of SSA to apply special rules to kidney transplant recipients receiving additional coverage for immunosuppressive drugs. Deems such individual to be enrolled under Medicare part B. Makes him or her responsible for the full amount of the applicable premiums. Applies deductible and coinsurance requirements to the provision of such drugs. Amends the Public Health Service Act, the Employee Retirement Income Security Act of 1974 (ERISA), and the Internal Revenue Code to set forth requirements for group health plans to provide coverage of immunosuppressive drugs for kidney transplant patients.

comprehensive immunosuppressive drug coverage kidney transplant patients act amends ssa title survivors disability insurance oasdi continue entitlement prescription drugs immunosuppressive therapy furnished individual receives kidney transplant payment medicare extend medicare secondary payer requirements end stage renal disease esrd beneficiaries amends title xviii medicare ssa apply special rules kidney transplant recipients receiving additional coverage immunosuppressive drugs deems individual enrolled medicare responsible applicable premiums applies deductible coinsurance requirements provision drugs amends public_health_service_act employee retirement income security act erisa internal revenue code set forth requirements group health plans provide coverage immunosuppressive drugs kidney transplant patients


Summary: Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007 - Amends title XVIII (Medicare) of the Social Security Act to require the Secretary of Health and Human Services to: (1) make incentive payments for physician use of an electronic prescription drug program (E-prescribing); and (2) reduce by 10% the fee schedule amount for failure to use E-prescribing. Directs the Administrator of the Centers for Medicare & Medicaid Services to report to Congress on progress on implementing E-prescribing under the Medicare electronic prescription drug program.

meds act amends title xviii medicare social security act require secretary health_and_human_services incentive payments physician use electronic prescription drug program prescribing reduce fee schedule failure use prescribing directs administrator centers report congress progress implementing prescribing medicare electronic prescription drug program


Summary: Reforming an Entitlement through Premium Adjustments based on Income Resources (REPAIR) Act of 2007 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to require an income-related reduction in the part D premium subsidy. Declares that, in the case of an individual whose modified adjusted gross income exceeds a certain applicable threshold amount for a month after December 2008, the monthly amount of the part D premium subsidy shall be reduced (and the monthly beneficiary premium shall be increased) by the monthly adjustment amount determined according to a specified formula.

reforming entitlement based act amends voluntary prescription drug benefit program title xviii medicare social security act require income related reduction premium subsidy declares case individual modified adjusted gross income exceeds certain applicable threshold month december monthly premium subsidy shall reduced monthly beneficiary premium shall increased monthly adjustment determined according specified formula


Summary: Equity in Prescription Insurance and Contraceptive Coverage Act of 2007 [sic] - Amends the Employee Retirement Income Security Act of 1974 (ERISA) and the Public Health Service Act to prohibit a group health plan, and a health insurance issuer providing group coverage, from: (1) excluding or restricting benefits for prescription contraceptive drugs, devices, and outpatient services if the plan provides benefits for other outpatient prescription drugs, devices, or outpatient services; (2) denying eligibility based on use or potential use of such items or services; (3) providing monetary payments or rebates to a covered individual to encourage acceptance of less than the minimum protections available; (4) penalizing, reducing, or limiting a professional's reimbursement because the professional prescribed such drugs or devices or provided such services; or (5) providing incentives to a professional to induce the professional to withhold such drugs, devices, or services. Applies such prohibitions to coverage offered in the individual market.

equity prescription insurance contraceptive coverage act sic amends employee retirement income security act erisa public_health_service_act prohibit group health plan health insurance issuer providing group coverage excluding restricting benefits prescription contraceptive drugs devices outpatient services plan provides benefits outpatient prescription drugs devices outpatient services denying eligibility based use potential use items services providing monetary payments rebates covered individual encourage acceptance minimum protections available penalizing reducing limiting professional reimbursement professional prescribed drugs devices provided services providing incentives professional induce professional withhold drugs devices services applies prohibitions coverage offered individual market


Summary: Medicare Prescription Drug Savings and Choice Act of 2009 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to provide for: (1) establishment of one or more Medicare operated prescription drug plan options; and (2) an appeals process for denials of benefits under a Medicare operated prescription drug plan.

medicare_prescription_drug_savings choice act amends voluntary prescription drug benefit program title xviii medicare social security act provide establishment medicare operated prescription drug plan options appeals process denials benefits medicare operated prescription drug plan


Summary: Amends title XVIII (Medicare) of the Social Security Act with respect to the use of average sales price methodology for calculating payments for drugs and biologicals under Medicare part B (Supplementary Medical Insurance). Excludes from the manufacturer's average sales price when calculating such payments any customary prompt pay discounts extended to wholesalers.

amends title xviii medicare social security act respect use average sales price methodology calculating payments drugs biologicals medicare supplementary_medical_insurance excludes manufacturer average sales price calculating payments customary prompt pay discounts extended wholesalers


Summary: Nino's Act - Amends title XIX (Medicaid) of the Social Security Act to provide for mandatory Medicaid coverage of drugs prescribed for certain research study child participants, regardless of Medicaid eligibility otherwise, if the state provides drug coverage.

act amends title xix medicaid social security act provide mandatory medicaid coverage drugs prescribed certain research study child participants regardless medicaid eligibility state provides drug coverage


Summary: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009 - Amends SSA title II (Old Age, Survivors and Disability Insurance) (OASDI) to: (1) continue entitlement to prescription drugs used in immunosuppressive therapy furnished to an individual who receives a kidney transplant for which payment is made under Medicare; and (2) extend Medicare secondary payer requirements for end stage renal disease (ESRD) beneficiaries. Amends title XVIII (Medicare ) of SSA to apply special rules to kidney transplant recipients receiving additional coverage for immunosuppressive drugs. Deems such individual to be enrolled under Medicare part B and makes the individual responsible for the full amount of the applicable premiums. Applies deductible and coinsurance requirements to the provision of such drugs. Amends the Public Health Service Act, the Employee Retirement Income Security Act of 1974 (ERISA), and the Internal Revenue Code to set forth requirements for group health plans to provide coverage of immunosuppressive drugs for kidney transplant patients.

comprehensive immunosuppressive drug coverage kidney transplant patients act amends ssa title survivors disability insurance oasdi continue entitlement prescription drugs immunosuppressive therapy furnished individual receives kidney transplant payment medicare extend medicare secondary payer requirements end stage renal disease esrd beneficiaries amends title xviii medicare ssa apply special rules kidney transplant recipients receiving additional coverage immunosuppressive drugs deems individual enrolled medicare makes individual responsible applicable premiums applies deductible coinsurance requirements provision drugs amends public_health_service_act employee retirement income security act erisa internal revenue code set forth requirements group health plans provide coverage immunosuppressive drugs kidney transplant patients


Summary: Medicare Drug Savings Through Choice Act of 2009 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to direct the Secretary of Health and Human Services to: (1) offer a Medicare operated prescription drug plan with a service area that consists of the entire United States; (2) negotiate with pharmaceutical manufacturers to reduce the purchase cost of covered Medicare part D drugs; and (3) encourage the use of more affordable therapeutic equivalents. Requires the monthly beneficiary premium charged under such a plan to be uniform nationally. Requires adjustment of such premium amount in case of supplemental prescription drug coverage.

amends voluntary prescription drug benefit program title xviii medicare social security act direct secretary health_and_human_services offer medicare operated prescription drug plan service area consists entire united_states negotiate pharmaceutical manufacturers reduce purchase cost covered medicare drugs encourage use affordable therapeutic equivalents requires monthly beneficiary premium charged plan uniform nationally requires adjustment premium case supplemental prescription drug coverage


Summary: Accountability and Transparency in Medicare Marketing Act of 2009 - Amends title XVIII (Medicare) of the Social Security Act to direct the Secretary of Health and Human Services (HHS) to request the National Association of Insurance Commissioners (NAIC) to develop standardized marketing requirements for: (1) Medicare Advantage organizations with respect to Medicare Advantage plans; and (2) prescription drug plan (PDP) sponsors with respect to Medicare PDPs. Requires such requirements to include prohibitions on certain activities and certain limitations. Requires state certification before HHS waiver of licensing requirements under the Medicare PDP. Directs the Secretary to request NAIC to establish a committee to study and make recommendations to the Secretary and Congress on the establishment of standardized benefit packages for Medicare Advantage plans and for Medicare PDPs and their regulation.

accountability transparency medicare marketing act amends title xviii medicare social security act direct secretary health_and_human_services hhs request national_association_of_insurance_commissioners naic develop standardized marketing requirements medicare advantage organizations respect medicare_advantage plans prescription drug plan pdp sponsors respect medicare pdps requires requirements include prohibitions certain activities certain limitations requires state certification hhs waiver licensing requirements medicare pdp directs secretary request naic establish committee study recommendations secretary congress establishment standardized benefit packages medicare_advantage plans medicare pdps regulation


Summary: Medication Therapy Management Benefits Act of 2009 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act (SSA) to require that the medication therapy management (MTM) services prescription drug plan (PDP) sponsors offer to targeted beneficiaries include: (1) an annual comprehensive medication review furnished person-to-person by a licensed pharmacist; (2) at least quarterly targeted medication reviews, also furnished person-to-person by a licensed pharmacist; and (3) followup interventions, person-to-person or through other interactive means, on a schedule and frequency recommended by the prescriber or a licensed pharmacist. Increases the number of diseases and conditions for which beneficiaries may be targeted for MTM services. Requires a PDP sponsor to identify a process, subject to approval by the Secretary of Health and Human Services (HHS), that allows pharmacists or other qualified providers to identify enrollees for MTM interventions where such individuals are not targeted beneficiaries or are not otherwise offered MTM services. Requires any MTM program to offer both comprehensive and targeted medication reviews to individuals dually eligible for both Medicare and Medicaid (under SSA title XIX), regardless of whether they are MTM-targeted beneficiaries. Requires a PDP sponsor to offer any willing pharmacy in its network the ability to provide MTM services. Requires the PDP sponsor to reimburse pharmacists and other entities furnishing MTM services based on the resources used and the time required to provide such services. Directs the Secretary to: (1) establish measures and standards for data collection by PDP sponsors to evaluate performance of pharmacies and other entities in furnishing MTM services; and (2) support the continued development and refinement of performance measures. Provides pharmacies and other entities that furnish MTM services with additional incentive payments based on their performance in meeting quality measures established under this Act.

medication therapy management benefits act amends voluntary prescription drug benefit program title xviii medicare social security act ssa require medication therapy management services prescription drug plan pdp sponsors offer targeted beneficiaries include annual comprehensive medication review furnished person person licensed pharmacist quarterly targeted medication reviews furnished person person licensed pharmacist interventions person person interactive means schedule frequency recommended prescriber licensed pharmacist increases number diseases conditions beneficiaries targeted services requires pdp sponsor identify process subject approval secretary health_and_human_services hhs allows pharmacists qualified providers identify enrollees interventions individuals targeted beneficiaries offered services requires program offer comprehensive targeted medication reviews individuals dually eligible medicare medicaid ssa title xix regardless targeted beneficiaries requires pdp sponsor offer willing pharmacy network ability provide services requires pdp sponsor reimburse pharmacists entities furnishing services based resources time required provide services directs secretary establish measures standards data collection pdp sponsors evaluate performance pharmacies entities furnishing services support continued development refinement performance measures provides pharmacies entities furnish services additional incentive payments based performance meeting quality measures established act


Summary: Helping Seniors Choose their Medicare Drug Plan - Amends Part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act with respect to the process for enrolling a full-benefit dual eligible individual (eligible for both Medicare and Medicaid benefits), who has otherwise failed to enroll in a prescription drug plan (PDP) or in an MedicareAdvantage-Prescription Drug (MA-PD) plan, in a PDP with a beneficiary premium that does not exceed a full premium subsidy. Repeals the requirement that the Secretary of Health and Human Services (HHS) enroll such an individual on a random basis among all plans in the PDP region. Requires the Secretary to enroll the individual in the most appropriate plan based on guidelines, established by the Secretary, that account for the individual's previous prescription drug utilization.

helping seniors choose medicare drug plan amends voluntary prescription drug benefit program title xviii medicare social security act respect process enrolling benefit dual eligible individual eligible medicare medicaid benefits failed enroll prescription drug plan pdp ma-pd plan pdp beneficiary premium exceed premium subsidy repeals requirement secretary health_and_human_services hhs enroll individual random basis plans pdp region requires secretary enroll individual appropriate plan based guidelines established secretary account individual previous prescription drug utilization


Summary: Steps Toward Access and Reform Act of 2009 or the STAR Act of 2009 - Sets conditions for lawsuits arising from health care liability claims regarding health care goods or services or any medical product affecting interstate commerce. Sets a statute of limitations of three years after the date of manifestation of injury or one year after the claimant discovers the injury, with certain exceptions. Provides that nothing in this Act limits recovery of the full amount of available economic damages. Limits noneconomic damages to $250,000. Makes each party liable only for the amount of damages directly proportional to such party's percentage of responsibility. Allows the court to restrict the payment of attorney contingency fees. Limits the fees to a decreasing percentage based on the increasing value of the amount awarded. Allows the introduction of collateral source benefits and the amount paid to secure such benefits as evidence. Prohibits a provider of such benefits from recovering any amount from an award in a health care lawsuit involving injury or wrongful death. Authorizes the award of punitive damages only where: (1) it is proven by clear and convincing evidence that a person acted with malicious intent to injure the claimant or deliberately failed to avoid unnecessary injury the claimant was substantially certain to suffer; and (2) compensatory damages are awarded. Limits punitive damages to the greater of two times the amount of economic damages or $250,000. Denies punitive damages in the case of products approved, cleared, or licensed by the Food and Drug Administration (FDA) or otherwise considered in compliance with FDA standards. Provides for periodic payments of future damages. Directs the Secretary of Health and Human Services (HHS) to carry out a program of loan forgiveness for primary health care providers who agree to provide medical services in medically underserved communities for a period of not less than four years. Amends the Internal Revenue Code to allow: (1) providers of medical care a bad debt tax deduction for up to 75% of their cost in providing uncompensated medical care to low-income individuals; and (2) a refund of excise tax on fuel used in mobile mammography vehicles; and (3) a tax deduction for the travel expenses of veterans and a family member to a medical center of the Department of Veterans Affairs. Amends the Bipartisan Trade Promotion Authority Act of 2002 to include among the overall trade negotiating objectives of the United States avoiding negotiating trade agreements that could restrict, or be interpreted to restrict, the access of consumers in the United States to certain pharmaceutical imports. Amends title XVIII (Medicare) of the Social Security Act to authorize payment after January 1, 2010, for chest radiology services that use computer-aided detection technology for the early detection of lung cancer.

steps access reform act star act sets conditions lawsuits arising health care liability claims health care goods services medical product affecting interstate commerce sets statute limitations years date manifestation injury year claimant discovers injury certain exceptions provides act limits recovery available economic damages limits noneconomic damages makes party liable damages directly proportional party percentage responsibility allows court restrict payment attorney contingency fees limits fees decreasing percentage based increasing value awarded allows introduction collateral source benefits paid secure benefits evidence prohibits provider benefits recovering award health care lawsuit involving injury wrongful death authorizes award punitive damages proven clear convincing evidence person acted malicious intent injure claimant deliberately failed avoid unnecessary injury claimant substantially certain suffer compensatory damages awarded limits punitive damages greater times economic damages denies punitive damages case products approved cleared licensed food_and_drug_administration fda considered compliance fda standards provides periodic payments future damages directs secretary health_and_human_services hhs carry program loan forgiveness primary health care providers agree provide medical services medically underserved communities period years amends internal revenue code allow providers medical care bad debt tax deduction cost providing uncompensated medical care low income individuals refund excise tax fuel mobile mammography vehicles tax deduction travel expenses veterans family member medical center department_of_veterans_affairs amends include overall trade negotiating objectives united_states avoiding negotiating trade agreements restrict interpreted restrict access consumers united_states certain pharmaceutical imports amends title xviii medicare social security act authorize payment january chest services use computer aided detection technology early detection lung cancer


Summary: Patient Health and Real Medication Access Cost Savings Act of 2009 or the PHARMACY Bill - Declares that a consumer shall have the right to choose to purchase prescription drugs from any domestic pharmacy that meets all applicable federal and state license and permit requirements. Directs the Secretary of Health and Human Services (HHS) to issue regulations that: (1) prohibit a pharmacy benefit manager (PBM) from providing incentives to, encouraging, or requiring pharmacy benefit plan enrollees to use certain pharmacies or from excluding an eligible pharmacy from a plan's pharmacy network; (2) require a PBM to ensure that pharmacy benefit plan enrollees pay a specified copayment for brand name drugs; (3) require a PBM to reimburse a pharmacy in the network of a pharmacy benefit plan that is federally funded, at specified rates, for brand-name drugs, generic drugs, and additional professional services; (4) require a PBM to be reimbursed by a pharmacy benefit plan sponsor for adjudicating and processing claims; (5) limit the amount that a PBM charges a pharmacy benefit plan sponsor for a drug that is dispensed to enrollees to the amount the PBM paid the pharmacy for such drug; (6) require a manufacturer of prescription drugs to pay all rebates directly to the pharmacy benefit plan sponsor and not to a PBM; and (7) require a pharmacy benefit plan sponsor to provide a list of the wholesale acquisition costs of the top 500 most frequently prescribed drugs to physicians in a plan any insurance-related charge of which is underwritten by a federal, state, or local government. Amends title XVIII (Medicare) of the Social Security Act to include pharmacist services as "medical and other health services" under Medicare. Directs the Secretary, by January 1, 2011, to establish a pharmaceutical access program to provide affordable prescription drugs to individuals who receive drug benefits under federal programs (except Medicaid). Requires: (1) a pharmacy that dispenses prescription drugs in the United States to remit to the Secretary 50 cents for each brand name prescription and $1.00 for generic drug prescription dispensed; and (2) the sponsor of a pharmacy benefit plan that is not federally funded to increase the professional dispensing fee paid to pharmacies by the same amounts. Requires the use of funds generated from such fees to provide affordable access to prescription drugs to low-income individuals who have enrolled in the program.

patient health real medication access cost savings act pharmacy bill declares consumer shall right choose purchase prescription drugs domestic pharmacy meets applicable federal state license permit requirements directs secretary health_and_human_services hhs issue regulations prohibit pharmacy benefit manager pbm providing incentives encouraging requiring pharmacy benefit plan enrollees use certain pharmacies excluding eligible pharmacy plan pharmacy network require pbm ensure pharmacy benefit plan enrollees pay specified copayment brand drugs require pbm reimburse pharmacy network pharmacy benefit plan federally funded specified rates brand drugs generic drugs additional professional services require pbm reimbursed pharmacy benefit plan sponsor adjudicating processing claims limit pbm charges pharmacy benefit plan sponsor drug dispensed enrollees pbm paid pharmacy drug require manufacturer prescription drugs pay rebates directly pharmacy benefit plan sponsor pbm require pharmacy benefit plan sponsor provide list wholesale acquisition costs frequently prescribed drugs physicians plan insurance related charge underwritten federal state local government amends title xviii medicare social security act include pharmacist services medical health services medicare directs secretary january establish pharmaceutical access program provide affordable prescription drugs individuals receive drug benefits federal programs medicaid requires pharmacy dispenses prescription drugs united_states remit secretary cents brand prescription generic drug prescription dispensed sponsor pharmacy benefit plan federally funded increase professional dispensing fee paid pharmacies amounts requires use funds generated fees provide affordable access prescription drugs low income individuals enrolled program


Summary: Medicare Prescription Drug Price Negotiation Act of 2010 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to direct the Secretary of Health and Human Services (HHS) to negotiate with pharmaceutical manufacturers the prices that may be charged to Medicare part D prescription drug plan (PDP) sponsors and MedicareAdvantage (MA) organizations for covered part D drugs for part D eligible individuals who are enrolled under a PDP or under an MA-Prescription Drug (MA-PD) plan.

medicare prescription drug price negotiation act amends voluntary prescription drug benefit program title xviii medicare social security act direct secretary health_and_human_services hhs negotiate pharmaceutical manufacturers prices charged medicare prescription drug plan pdp sponsors medicareadvantage organizations covered drugs eligible individuals enrolled pdp ma-prescription_drug ma-pd plan


Summary: Part D Off-Label Prescription Parity Act - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to permit a prescription drug plan (PDP) sponsor offering a PDP or a MedicareAdvantage (MA) organization offering an MA-PD plan to offer coverage of covered part D drugs for uses that are determined to be for medically accepted indications based upon: (1) guidance provided by the Secretary of Health and Human Services (HHS) for determining accepted uses of covered part D drugs; and (2) supportive clinical evidence in peer reviewed medical literature.

label prescription parity act amends voluntary prescription drug benefit program title xviii medicare social security act permit prescription drug plan pdp sponsor offering pdp medicareadvantage organization offering ma-pd plan offer coverage covered drugs uses determined medically accepted indications based guidance provided secretary health_and_human_services hhs determining accepted uses covered drugs supportive clinical evidence peer reviewed medical literature


Summary: Amends the Public Health Service Act to consider certain drugs designated for a rare disease or condition as covered outpatient drugs for children's hospitals under the 340B drug discount program (a program limiting the cost of covered outpatient drugs to certain federal grantees).

amends public_health_service_act consider certain drugs designated rare disease condition covered outpatient drugs children hospitals 340b drug discount program program limiting cost covered outpatient drugs certain federal grantees


Summary: Medicare Prescription Drug Gap Reduction Act of 2009 - Amends title XVIII (Medicare) of the Social Security Act (SSA) to reduce the coverage gap in prescription drug coverage under SSA part D (Voluntary Prescription Drug Benefit Program), based on savings to the Medicare program resulting from the negotiation of prescription drug prices. Grants the Secretary of Health and Human Services authority similar to that of other federal entities that purchase prescription drugs in bulk to negotiate contracts with manufacturers of covered part D drugs. States that the Secretary shall be required to: (1) negotiate contracts with manufacturers of covered part D drugs for each fallback prescription drug plan; and (2) participate in negotiation of contracts of any covered part D drug upon request of an approved prescription drug plan or Medicare Advantage Prescription Drug Plan. Prohibits the Secretary from requiring a particular formulary or instituting a price structure for the reimbursement of covered part D drugs in order to carry out, and promote competition, under part D.

amends title xviii medicare social security act ssa reduce coverage gap prescription drug coverage ssa voluntary prescription drug benefit program based savings medicare program resulting negotiation prescription drug prices grants secretary health_and_human_services authority similar federal entities purchase prescription drugs bulk negotiate contracts manufacturers covered drugs states secretary shall required negotiate contracts manufacturers covered drugs fallback prescription drug plan participate negotiation contracts covered drug request approved prescription drug plan prohibits secretary requiring particular formulary instituting price structure reimbursement covered drugs order carry promote competition


Summary: Access to Durable Medical Equipment Act - Amends part B (Supplementary Medical Insurance) of title XVIII (Medicare) of the Social Security Act, as amended by the Medicare Improvements for Patients and Providers Act of 2008, with respect to Medicare quality standards for suppliers of items and services which shall be applied by recognized independent accreditation organizations. Applies to pharmacies and pharmacists the eligible professional exemption from such accreditation requirements, unless such standards are designed specifically for application to pharmacies and pharmacists. Authorizes the Secretary of Health and Human Services to exempt pharmacies and pharmacists from such standards if licensing, accreditation, or other mandatory quality requirements apply to them with respect to the furnishing of items and services.

access durable medical equipment act amends supplementary_medical_insurance title xviii medicare social security act amended medicare_improvements_for_patients_and_providers_act respect medicare quality standards suppliers items services shall applied recognized independent accreditation organizations applies pharmacies pharmacists eligible professional exemption accreditation requirements standards designed specifically application pharmacies pharmacists authorizes secretary health_and_human_services exempt pharmacies pharmacists standards licensing accreditation mandatory quality requirements apply respect furnishing items services


Summary: Reforming an Entitlement through Premium Adjustments based on Income Resources (REPAIR) Act of 2009 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to require an income-related reduction in the part D premium subsidy. Declares that, in the case of an individual whose modified adjusted gross income exceeds a certain applicable threshold amount for a month after December 2009, the monthly amount of the part D premium subsidy shall be reduced (and the monthly beneficiary premium shall be increased) by the monthly adjustment amount determined according to a specified formula.

reforming entitlement based act amends voluntary prescription drug benefit program title xviii medicare social security act require income related reduction premium subsidy declares case individual modified adjusted gross income exceeds certain applicable threshold month december monthly premium subsidy shall reduced monthly beneficiary premium shall increased monthly adjustment determined according specified formula


Summary: 340B Program Improvement and Integrity Act of 2009 - Amends the Public Health Service Act to expand the drug discount program to allow participation as a covered entity by certain: (1) children's hospitals; (2) critical access hospitals; and (3) rural referral centers. Expands the program to include drugs used in connection with an inpatient or outpatient service by enrolled hospitals (currently, only outpatient drugs are covered under the program). Prohibits enrolled hospitals from obtaining covered outpatient drugs through a group purchasing arrangement. Requires the Secretary of Health and Human Services (HHS) to establish reasonable exceptions to such prohibition, including for drugs unavailable through the program and to facilitate generic substitution when a generic covered drug is available at a lower price. Requires a hospital enrolled in the 340B drug discount program to issue a credit to a state Medicaid program for inpatient drugs provided to Medicaid recipients. Requires the Secretary to: (1) provide for improvements in compliance by manufacturers and covered entities with the requirements of the drug discount program; and (2) establish and implement an administrative process for resolving claims by covered entities and manufacturers of violations of such requirements. Requires manufacturers to offer each covered entity covered drugs for purchase at or below the applicable ceiling price if such a drug is made available to any other purchaser at any price.

integrity act amends public_health_service_act expand drug discount program allow participation covered entity certain children hospitals critical access hospitals rural referral centers expands program include drugs connection inpatient outpatient service enrolled hospitals currently outpatient drugs covered program prohibits enrolled hospitals obtaining covered outpatient drugs group purchasing arrangement requires secretary health_and_human_services hhs establish reasonable exceptions prohibition including drugs unavailable program facilitate generic substitution generic covered drug available lower price requires hospital enrolled 340b drug discount program issue credit state medicaid program inpatient drugs provided medicaid recipients requires secretary provide improvements compliance manufacturers covered entities requirements drug discount program establish implement administrative process resolving claims covered entities manufacturers violations requirements requires manufacturers offer covered entity covered drugs purchase applicable ceiling price drug available purchaser price


Summary: Medicare Safe Needle Disposal Coverage Act of 2009 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to cover as a part D drug any devices approved for home use by the Food and Drug Administration (FDA) for the safe and effective containment, removal, decontamination, and disposal of home-generated needles, syringes, and other sharps through a sharps container, decontamination/destructive device, or sharps-by-mail program or similar program.

medicare_safe_needle_disposal_coverage_act amends voluntary prescription drug benefit program title xviii medicare social security act cover drug devices approved home use food_and_drug_administration fda safe effective containment removal decontamination disposal home generated needles syringes sharps sharps container decontamination destructive device sharps mail program similar program